ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
84.12
-0.39 (-0.46%)
At close: Jun 29, 2026, 4:00 PM EDT
84.11
0.00 (-0.01%)
After-hours: Jun 29, 2026, 5:29 PM EDT
ANI Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, ANI Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $112.71. The average 1-year stock price forecast is 34.00% higher than the current stock price, while the lowest is $100 (+18.88%) and the highest is $124 (+47.42%).
Price Target: $112.71 (+34.00%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 20, 2026.
Analyst Ratings
The average analyst rating for ANI Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $100 | Buy | Maintains | $100 | +18.88% | May 20, 2026 |
| Truist Financial | Truist Financial | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 11, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $124 | Buy | Reiterates | $124 | +47.42% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $121 | Buy | Reiterates | $121 | +43.85% | May 8, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 8, 2026 |
Financial Forecast
Revenue This Year
1.12B
from 883.37M
Increased by 26.47%
Revenue Next Year
1.24B
from 1.12B
Increased by 11.34%
EPS This Year
9.37
from 7.89
Increased by 18.72%
EPS Next Year
10.69
from 9.37
Increased by 14.18%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.1B | ||
| Avg | 1.1B | ||
| Low | 1.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 28.4% | ||
| Avg | 26.5% | ||
| Low | 25.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.60 | ||
| Avg | 9.37 | ||
| Low | 9.19 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.7% | ||
| Avg | 18.7% | ||
| Low | 16.5% |